Trump Administration Promotes a Drug Pricing Plan - On Friday, May 11, 2018, President Trump announced a drug pricing blueprint to address prescription drug prices. Initial media coverage of the plan suggested that the blueprint failed to honor the President’s campaign commitment to negotiation of drug prices. Overall, the press and policymaker reaction to the plan was muted, with some suggesting that the plan would have limited impact. [...]

What Caught Our Eye (WCOE) is our week-in-review blog series. “Making Heath Insurance Enrollment As Automatic As Possible” — Via Health Affairs Blog — In December 2017, the Republican Congress, working with the Trump administration, repealed the tax penalties enforcing the Affordable Care Act’s (ACA) individual mandate, effective in 2019. Although the degree of the mandate’s efficacy is uncertain, its repeal is sure to lead to additional Americans [...]

If you haven’t already submitted comments regarding the short-term limited-duration proposed rule, please take 5 minutes to do so before the deadline on Monday night! NCCS recently hosted a webinar on what these short-term plans mean for cancer survivors. See the webinar blog post for step-by-step instructions on how to submit comments to ensure cancer patients’ voices are heard. Another ACA development occurred this week. [...]